表紙
市場調查報告書

次世代定序 (NGS)的全球市場:2019年∼2023年

Next Generation Sequencing Market by Technology, Product, End-users, and Geography - Global Forecast and Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 910712
出版日期 內容資訊 英文 152 Pages
訂單完成後即時交付
價格
次世代定序 (NGS)的全球市場:2019年∼2023年 Next Generation Sequencing Market by Technology, Product, End-users, and Geography - Global Forecast and Analysis 2019-2023
出版日期: 2019年09月05日內容資訊: 英文 152 Pages
簡介
預計變成

全球次世代定序市場上,NGS方法的使用率增加,對遺傳性疾病的早期診斷的需求增加,廣泛的NGS產品的可得性等成長促進因素,在預測期間內將以19%以上的年複合成長率擴大。

本報告提供全球次世代定序 (NGS) 市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模 (2018年)
  • 市場規模及預測 (2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各技術

  • 市場區隔:各技術

第7章 市場區隔化:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測 (2018年∼2023年)
  • 消耗品
  • 設備
  • 市場機會:各產品

第8章 客戶形勢

第9章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶

第10章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測 (2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • NGS技術的進步
  • 遺傳基因序列測定的降低成本
  • 在生物資訊學及雲端基礎的軟體領域的發展

第14章 業者情勢

  • 概要
  • 創造性破壞狀況

第15章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN Group
  • Thermo Fisher Scientific Inc.

第16章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第17章 關於TECHNAVIO

目錄
Product Code: IRTNTR31979

About this market

Technavio's next generation sequencing market analysis considers sales from both consumables and equipment products. Our analysis also considers the sales of next generation sequencing in Asia, Europe, North America, and ROW. In 2018, the consumables segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as technological advances, and repetitive purchase of a broad range of NGS consumables such as test kits, assays, buffers, and reagents will play a significant role in the consumables segment to maintain its market position. Also, our global next generation sequencing market report looks at factors such as increased utilization of NGS methods, G rowing demand for early diagnosis of genetic disorders, availability of wide range of NGS products. However, lack of clinical validation on direct-to-consumer genetic tests, limited reimbursement policies, and challenges in implementing NGS workflow may hamper the growth of the next generation sequencing industry over the forecast period.

Overview

Growing demand for early diagnosis of genetic disorders

The need to prevent physical disabilities and health conditions in newborns is increasing the demand for early diagnosis among expecting parents. Pre-implantation diagnostic tests facilitates the determination of genetic disorders, such as cystic fibrosis, congenital hearing loss, and thalassemia. Thus, parents are increasingly opting for preimplantation testing, which increases the adoption of NGS techniques. Sequencing technology allows for a simple PGS workflow with flexible sample throughput for consistent and quick aneuploidy detection. Thus, the growing demand for early diagnosis of genetic disorders will drive the growth of the next generation sequencing market at a CAGR of over 19% during the forecast period.

Reduced costs of gene sequencing

Advances in high-throughput genetic testing procedures, biochip, and new generation sequencing (NGS) techniques have reduced the costs of gene sequencing significantly. This has led the vendors to offer low-cost services and overcome cost-related challenges . The adoption of next generation sequencing and fluorescence-based dully automated sequencing technologies have also reduced the cost of sequencing and improved the accuracy in gene sequencing. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global next generation sequencing market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global next generation sequencing market is moderately fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing manufacturers, that include Bio-Rad Laboratories Inc., Eurofins GSC Lux Sarl, F. Hoffmann-La Roche Ltd., Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Merck KGaA, PerkinElmer Inc., QIAGEN Group, Thermo Fisher Scientific Inc.

Also, the next generation sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TECHNOLOGY

  • Market segmentation by technology

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Consumables - Market size and forecast 2018-2023
  • Equipment - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Advances in NGS techniques
  • Reduced costs of gene sequencing
  • Developments in the field of bioinformatics and cloud-based software
  • programs

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN Group
  • Thermo Fisher Scientific Inc.

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Vendor offering overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Equipment - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Equipment - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by end-user 2018 (%)
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 46: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 47: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 48: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 49: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 50: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 51: Eurofins GSC Lux Sarl - Vendor overview
  • Exhibit 52: Eurofins GSC Lux Sarl - Business segments
  • Exhibit 53: Eurofins GSC Lux Sarl - Organizational developments
  • Exhibit 54: Eurofins GSC Lux Sarl - Geographic focus
  • Exhibit 55: Eurofins GSC Lux Sarl - Segment focus
  • Exhibit 56: Eurofins GSC Lux Sarl - Key offerings
  • Exhibit 57: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 58: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 59: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 60: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 61: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 62: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 63: Illumina Inc. - Vendor overview
  • Exhibit 64: Illumina Inc. - Business segments
  • Exhibit 65: Illumina Inc. - Organizational developments
  • Exhibit 66: Illumina Inc. - Geographic focus
  • Exhibit 67: Illumina Inc. - Segment focus
  • Exhibit 68: Illumina Inc. - Key offerings
  • Exhibit 69: Invitae Corp. - Vendor overview
  • Exhibit 70: Invitae Corp. - Business segments
  • Exhibit 71: Invitae Corp. - Organizational developments
  • Exhibit 72: Invitae Corp. - Geographic focus
  • Exhibit 73: Invitae Corp. - Key offerings
  • Exhibit 74: Laboratory Corp. of America Holdings - Vendor overview
  • Exhibit 75: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 76: Laboratory Corp. of America Holdings - Organizational developments
  • Exhibit 77: Laboratory Corp. of America Holdings - Geographic focus
  • Exhibit 78: Laboratory Corp. of America Holdings - Segment focus
  • Exhibit 79: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 80: Merck KGaA - Vendor overview
  • Exhibit 81: Merck KGaA - Business segments
  • Exhibit 82: Merck KGaA - Organizational developments
  • Exhibit 83: Merck KGaA - Geographic focus
  • Exhibit 84: Merck KGaA - Segment focus
  • Exhibit 85: Merck KGaA - Key offerings
  • Exhibit 86: PerkinElmer Inc. - Vendor overview
  • Exhibit 87: PerkinElmer Inc. - Business segments
  • Exhibit 88: PerkinElmer Inc. - Organizational developments
  • Exhibit 89: PerkinElmer Inc. - Geographic focus
  • Exhibit 90: PerkinElmer Inc. - Segment focus
  • Exhibit 91: PerkinElmer Inc. - Key offerings
  • Exhibit 92: QIAGEN Group - Vendor overview
  • Exhibit 93: QIAGEN Group - Product segments
  • Exhibit 94: QIAGEN Group - Organizational developments
  • Exhibit 95: QIAGEN Group - Geographic focus
  • Exhibit 96: QIAGEN Group - Segment focus
  • Exhibit 97: QIAGEN Group - Key offerings
  • Exhibit 98: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 99: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 100: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 101: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 102: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 103: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 104: Validation techniques employed for market sizing
  • Exhibit 105: Definition of market positioning of vendors